New dementia drugs and therapies: What Canadians should know
That Pricey New Alzheimer's Drug? Still Not Great
Hope and anxiety surround new Alzheimer’s drug lecanemab
Growing hope over a new Alzheimer's drug, but there are side effects
New Alzheimer's drug shows promise in slowing disease
The state of dementia research in Canada | The Social
A potential breakthrough in Alzheimer’s research needs Canadians’ help to move forward
Alzheimer's drug hailed as breakthrough, but may have side effects
New Alzheimer's Medication Treatment
How a new kind of drug could change the future of Alzheimer’s
'Lecanemab' : New drug for Alzheimer's Disease could be pathbreaking
Dementia on the rise in Canada, Ontario borrows from European treatment models
New treatments for dementia? [5 considerations]
Research links widely-used drugs to a higher risk of dementia
New Alzheimer's drug is the 'beginning of the end' | Professor Michael Woodward
Debating the risks, benefits of a controversial Alzheimer's drug
FDA approves controversial Biogen Alzheimer's drug | DW News
New Alzheimer's drug slows disease by a third - BBC News
Drug slows cognitive decline in patients with early stages of Alzheimer's disease | The World
Discussing Alzheimer’s in Canada | The Social
